← Leaderboards
William M Pardridge
University Of California Los Angeles
$11,519,163
Attributed
$11,519,163
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$11,519,163 · 12
By mechanism
R01$8,167,770 · 7
R44$2,146,155 · 2
R33$628,230 · 1
R21$305,041 · 1
T32$271,967 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ruben J. Boado$14,771,226
- Isidro B. Benjamin Salusky$22,568,917
Others in their field
Top investigators on “Transferrin Receptor”
- Caroline Enns · Yeshiva University$10,970,817
- Tomas Kirchhausen · Boston Children'S Hospital$9,735,328
- Colin R. Parrish · Cornell University Ithaca$9,634,585
- Cynthia Nau Cornelissen · Virginia Commonwealth University$8,811,850
- Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med$6,852,311
- Manuel L Penichet · University Of California Los Angeles$6,528,241
Research focus
Transferrin ReceptorBlood Brain BarrierBrainBlood - Brain Barrier AnatomyMediatingMonoclonal AntibodiesIn VivoChimeric ProteinsComplementary DnaTranscytosisDrug Delivery SystemsGenesImmunocytochemistryReceptorLaboratory RatDoseCerebral Ischemia /HypoxiaMolecular Trojan HorseMonoclonal AntibodyPharmaceutical PreparationsPlasmidsBloodNovel TherapeuticsRattus
Grant awards (42)
New Treatment of the Brain in Niemann Pick C$538,302
R44 · FY2018 · NS · contact PI
Brain DNA Therapeutics with Trojan Horse Liposomes$647,273
R44 · FY2017 · NS · contact PI
New Treatment of the Brain in Niemann Pick C$460,967
R44 · FY2017 · NS · contact PI
Brain DNA Therapeutics with Trojan Horse Liposomes$499,613
R44 · FY2016 · NS · contact PI
Neurotrophin Drug Development for Parkinson's Disease$330,138
R01 · FY2012 · NS · contact PI
Monoclonal Antibody Drug Development for Alzheimer's Disease$315,700
R01 · FY2012 · AG · contact PI
Neurotrophin Drug Development for Parkinson's Disease$330,138
R01 · FY2011 · NS · contact PI
Monoclonal Antibody Drug Development for Alzheimer?s Disease$463,860
R01 · FY2010 · AG · contact PI
Neurotrophin Drug Development for Parkinson's Disease$336,875
R01 · FY2010 · NS · contact PI
Monoclonal Antibody Drug Development for Alzheimer?s Disease$314,545
R01 · FY2009 · AG · contact PI
Monoclonal Antibody Drug Development for Alzheimer?s Disease$154,000
R01 · FY2009 · AG · contact PI
Monoclonal Antibody Drug Development for Alzheimer?s Disease$314,545
R01 · FY2008 · AG · contact PI
Non-Viral Gene Targeting to the Brain$303,790
R01 · FY2008 · NS · contact PI
Non-Viral Gene Targeting to the Brain$303,790
R01 · FY2007 · NS · contact PI
AIDS Neurotherapeutics and BBB Drug Efflux$256,365
R01 · FY2007 · MH · contact PI
Non-Viral Gene Targeting to the Brain$312,863
R01 · FY2006 · NS · contact PI
AIDS Neurotherapeutics and BBB Drug Efflux$264,022
R01 · FY2006 · MH · contact PI
Neurotrophin Blood/Brain Barrier Delivery in Ischemia$247,573
R01 · FY2006 · NS · contact PI
Antisense imaging of brain gene expression in vivo$304,170
R33 · FY2005 · CA
AIDS Neurotherapeutics and BBB Drug Efflux$270,229
R01 · FY2005 · MH
Neurotrophin Blood/Brain Barrier Delivery in Ischemia$253,531
R01 · FY2005 · NS
Antisense imaging of brain gene expression in vivo$324,060
R33 · FY2004 · CA
AIDS Neurotherapeutics and BBB Drug Efflux$268,479
R01 · FY2004 · MH
Neurotrophin Blood/Brain Barrier Delivery in Ischemia$253,531
R01 · FY2004 · NS
AIDS Neurotherapeutics and BBB Drug Efflux$266,875
R01 · FY2003 · MH
Neurotrophin Blood/Brain Barrier Delivery in Ischemia$253,531
R01 · FY2003 · NS
BLOOD BRAIN BARRIER LARGE NEUTRAL AMINO ACID TRANSPORTER$228,750
R01 · FY2003 · NS
Antisense imaging of brain gene expression in vivo$152,500
R21 · FY2003 · CA
AIDS THERAPEUTICS &BLOOD-BRAIN BARRIER AZT DRUG EFFLUX$229,500
R01 · FY2002 · MH
BLOOD/BRAIN BARRIER DRUG DELIVERY OF BDNF IN ISCHEMIA$226,111
R01 · FY2002 · NS
REGULATION OF BBB GLUT1 GLUCOSE TRANSPORTER$221,640
R01 · FY2002 · NS
Antisense imaging of brain gene expression in vivo$152,541
R21 · FY2002 · CA
AIDS THERAPEUTICS &BLOOD-BRAIN BARRIER AZT DRUG EFFLUX$229,500
R01 · FY2001 · MH
BLOOD/BRAIN BARRIER DRUG DELIVERY OF BDNF IN ISCHEMIA$220,848
R01 · FY2001 · NS
REGULATION OF BBB GLUT1 GLUCOSE TRANSPORTER$216,561
R01 · FY2001 · NS
NEUROSCIENCE TRAINING IN BLOOD-BRAIN BARRIER RESEARCH$98,943
T32 · FY2001 · NS
BLOOD/BRAIN BARRIER DRUG DELIVERY OF BDNF IN ISCHEMIA$50,000
R01 · FY2001 · NS
AIDS THERAPEUTICS &BLOOD-BRAIN BARRIER AZT DRUG EFFLUX$229,500
R01 · FY2000 · MH
BLOOD/BRAIN BARRIER DRUG DELIVERY OF BDNF IN ISCHEMIA$214,445
R01 · FY2000 · NS
REGULATION OF BBB GLUT1 GLUCOSE TRANSPORTER$210,285
R01 · FY2000 · NS
NEUROSCIENCE TRAINING IN BLOOD-BRAIN BARRIER RESEARCH$173,024
T32 · FY2000 · NS
REGULATION OF BBB GLUT1 GLUCOSE TRANSPORTER$76,250
R01 · FY2000 · NS